Systemic lupus erythematous (SLE) and immunodeficiency are linked in various ways. For example, rare genetic complement deficiencies can pre-dispose to developing SLE, whilst some treatments for SLE can cause secondary immunodeficiencies. Various case reports describe SLE patients who have concomitant or later develop antibody deficiency, possibly related to immunosuppressive treatment, or possibly related to the lupus itself. Other components of the immune system, innate and adaptive may also be affected. Immunosuppressive treatment may also cause infections in the absence of defects on routine immunological testing. It is important for the clinician to be aware of the associations between SLE and immunodeficiency to ensure optimal investigation and management. This review focuses on aspects of humoral and cellular immunity, and their association with SLE.
Walport MJ.Complement. Second of two parts . N Engl J Med2001; 344: 1140-1144 .
2.
Hudson-Peacock MJ , Joseph SA , Cox J , Munro CS , Simpson NB.Systemic lupus erythematosus complicating complement type 2 deficiency: successful treatment with fresh frozen plasma . Br J Dermato1997; 136: 388-392 .
3.
Tsutsumi A , Sasaki K , Wakamiya Net al.Mannose-binding lectin gene: polymorphisms in Japanese patients with systemic lupus erythematosus, rheumatoid arthritis and Sjogren’s syndrome . Genes Immun2001; 2: 99-104 .
4.
Horiuchi T , Tsukamoto H , Morita Cet al.Mannose binding lectin (MBL) gene mutation is not a risk factor for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) in Japanese . Genes Immun2000; 1: 464-466 .
5.
Mok MY , Jack DL , Lau CSet al.Antibodies to mannose binding lectin in patients with systemic lupus erythematosus . Lupus2004; 13: 522-528 .
6.
Seelen MA , Trouw LA , van der Hoorn JWet al.Autoantibodies against mannose-binding lectin in systemic lupus erythematosus . Clin Exp Immunol2003; 134: 335-343 .
7.
Turner MW.The role of mannose-binding lectin in health and disease . Mol Immunol2003; 40: 423-429 .
8.
Horiuchi T , Gondo H , Mivagawa Het al.Association of MBL gene polymorphisms with major bacterial infection in patients treated with high-dose chemotherapy and autologous PBSCT . Genes Immun2005; 6: 162-166 .
9.
Peterslund NA , Koch C , Jensenius JC , Thiel S.Association between deficiency of mannose-binding lectin and severe infections after chemotherapy . Lancet2001; 358: 637-638 .
10.
Hibberd ML , Sumiya M , Summerfield JA , Booy R , Levin M.Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Meningococcal Research Group . Lancet1999; 353: 1049-1053 .
11.
Garred P , Voss A , Madsen HO , Junker P.Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients . Genes Immun2001; 2: 442-450 .
12.
Porges AJ , Beattie SL , Ritchlin C , Kimberly RP , Christian CL.Patients with systemic lupus erythematosus at risk for Pneumocystis carinii pneumonia . J Rheumatol1992; 19: 1191-1194 .
13.
Foster HE , Malleson PN , Petty RE , Roberton DM , Cabral DA.Pneumocystis carinii pneumonia in childhood systemic lupus erythematosus . J Rheumatol1996; 23: 753-756 .
14.
Rankin EC , Isenberg DA.IgA deficiency and SLE: prevalence in a clinic population and a review of the literature . Lupus1997; 6: 390-394 .
15.
Lee AH , Levinson AI , Schumacher HR Jr.Hypogammaglobulinemia and rheumatic disease . Semin Arthritis Rheum1993; 22: 252-264 .
16.
Swaak AJ , van den Brink HG.Common variable immunodeficiency in a patient with systemic lupus erythematosus . Lupus1996; 5: 242-246 .
17.
Cronin ME , Balow JE , Tsokos GC.Immunoglobulin deficiency in patients with systemic lupus erythematosus . Clin Exp Rheumatol1989; 7: 359-364 .
18.
Tarrant TK , Frazer DH , Ava-Ay JP , Patel DD.B cell loss leading to remission in severe systemic lupus erythematosus . J Rheumatol2003; 30: 412-414 .
19.
Sussman GL , Rivera VJ , Kohler PF.Transition from systemic lupus erythematosus to common variable hypogammaglobulinemia . Ann Intern Med1983; 99: 32-35 .
20.
Goldstein R , Izaguirre C , Smith CD , Mierins E , Karsh J.Systemic lupus erythematosus and common variable panhypogammaglobulinemia: a patient with absence of circulating B cells . Arthritis Rheum1985; 28: 100-103 .
21.
Stein A , Winkelstein A , Agarwak A.Concurrent systemic lupus erythematosus and common variable hypogammaglobulinemia . Arthritis Rheum1985; 28: 462-465 .
22.
Draft PIN guidelines. 7.01 Diagnosis of Common Variable Immunodeficiency. Retreived 19 January 2006 from http://www.ukpin.org.uk/guidelines7-01.html
23.
Warnatz K , Wehr C , Drager Ret al.Expansion of CD19(hi)CD21(lo/neg) B cells in common variable immunodeficiency (CVID) patients with autoimmune cytopenia . Immunobiology2002; 206: 502-513 .
24.
Walport MJ.Complement. First of two parts . N Engl J Med2001; 344: 1058-1066 .
25.
Jonas MM , Baron MJ , Bresee JS , Schneider LC.Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin . Pediatrics1996; 98: 211-215 .
26.
Cambridge G , Leandro MJ , Edwards JCet al.Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis . Arthritis Rheum2003; 48: 2146-2154 .
27.
Anolik JH , Barnard J , Cappione Aet al.Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus . Arthritis Rheum2004; 50: 3580-3590 .
